Market Overview:
The global assisted reproductive technology (ART) market is expected to register a CAGR of 7.8% during the forecast period, 2018-2030. The fertility medication segment is expected to account for the largest share of the global ART market in 2018. The in vitro fertilization (IVF) segment is projected to grow at the highest CAGR during the forecast period. North America accounted for the largest share of the global ART market in 2017, and it is projected to maintain its dominance duringthe forecast period.
Product Definition:
The definition of Assisted Reproductive Technology is the use of technology to help couples conceive a child. This can include things like in vitro fertilization, or using donor eggs or sperm. The importance of Assisted Reproductive Technology is that it can help couples who are struggling to conceive a child have a chance at becoming parents.
General:
The global General is a low-cost, single-use, disposable medical device used in assisted reproductive technology (ART) to help the infertile couple have a baby. It consists of an injection and a retrieval system that enables men with poor sperm quality to produce normal sperm volume and count for artificial Insemination procedures.
Fertility Medication:
Fertility medication is a drug or combination of drugs used to help men and women achieve pregnancy. Fertility medications can either be taken by the man or by the woman. The most common types of fertility medications include Clomiphene Citrate (ClC), Human Chorionic Gonadotropin (hCG), and Sperm Extenders.
Application Insights:
Based on application, the market is segmented into fertility clinics, hospitals and others. Fertility clinics held the largest share in 2017 due to increasing demand for assisted reproductive technology from infertile couples. In addition, these centers offer a more personal approach to assisted reproductive technology by providing individualized treatment plans according to each couple¢â‚¬â„¢s unique situation. This personalized approach helps overcome some of the barriers that prevent infertile couples from adopting conventional methods of family planning such as condoms or birth control pills.
The hospital segment is expected to grow at a faster rate during the forecast period due to rising adoption of Assisted Reproductive Technology (ART) procedures among healthy women and men who have difficulty conceiving children naturally as well as those suffering from infertility problems caused by blocked tubes or low sperm count.
Regional Analysis:
North America dominated the global market in 2017. The fertility rate of women aged 35 years and above is considered to be a key factor for the growth of this region. According to CDC, around 60% of all American women will be above 35 years by 2050 and there will be an increase in infertility among them due to age-related factors. Thus, increasing infertility among aging women is expected to boost demand for ART procedures over the forecast period.
Asia Pacific has also been witnessing rapid economic development with countries such as China and India at its forefront; both are emerging economies with high fertility rates compared to other regions across the globe (around 2 children per woman).
Growth Factors:
- Increasing number of couples facing infertility issues: The increasing number of couples who are unable to conceive naturally is one of the key growth drivers for the assisted reproductive technology (ART) market. This is primarily because of the increase in awareness about ART and its procedures, and also the advancements in ART technologies.
- Rise in use of donor eggs and sperm: Another major factor that is driving growth in the ART market is the rise in use of donor eggs and sperm. This is mainly due to factors such as increasing age-related infertility, growing acceptance among couples regarding donation, and technological advancements making it easier to screen donors for genetic diseases.
- Growing demand for fertility treatments: The rising demand for fertility treatments across all regions has been a key driver for growth in the ART market over recent years. This can be attributed to various factors such as increased awareness about available treatment options, growing acceptance among people regarding assisted reproduction methods, and improvements made to existing technologies over time.
Scope Of The Report
Report Attributes
Report Details
Report Title
Assisted Reproductive Technology Market Research Report
By Type
General, Fertility Medication, In Vitro Fertilization, Others
By Application
Fertility Clinics, Hospitals, Others
By Companies
Vitrolife, Ferring Pharmaceuticals, Irvine Scientific, Cook Medical, CellCura, EMD Serono, Esco Micro, IKS International (Gonagen Medikal), INVO Bioscience, IVFtech, Smiths Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
132
Number of Tables & Figures
93
Customization Available
Yes, the report can be customized as per your need.
Global Assisted Reproductive Technology Market Report Segments:
The global Assisted Reproductive Technology market is segmented on the basis of:
Types
General, Fertility Medication, In Vitro Fertilization, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fertility Clinics, Hospitals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Vitrolife
- Ferring Pharmaceuticals
- Irvine Scientific
- Cook Medical
- CellCura
- EMD Serono
- Esco Micro
- IKS International (Gonagen Medikal)
- INVO Bioscience
- IVFtech
- Smiths Medical
Highlights of The Assisted Reproductive Technology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- General
- Fertility Medication
- In Vitro Fertilization
- Others
- By Application:
- Fertility Clinics
- Hospitals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Assisted Reproductive Technology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Assisted reproductive technology (ART) is a term used to describe various techniques that can be used to help couples conceive a child. These technologies include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic diagnosis (PGD). ART can also involve the use of donor eggs or sperm, which are then used in conjunction with the couple's own eggs or sperm.
Some of the major companies in the assisted reproductive technology market are Vitrolife, Ferring Pharmaceuticals, Irvine Scientific, Cook Medical, CellCura, EMD Serono, Esco Micro, IKS International (Gonagen Medikal), INVO Bioscience, IVFtech, Smiths Medical.
The assisted reproductive technology market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Assisted Reproductive Technology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Assisted Reproductive Technology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Assisted Reproductive Technology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Assisted Reproductive Technology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Assisted Reproductive Technology Market Size & Forecast, 2020-2028
4.5.1 Assisted Reproductive Technology Market Size and Y-o-Y Growth
4.5.2 Assisted Reproductive Technology Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 General
5.2.2 Fertility Medication
5.2.3 In Vitro Fertilization
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Fertility Clinics
6.2.2 Hospitals
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Assisted Reproductive Technology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Assisted Reproductive Technology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 General
9.6.2 Fertility Medication
9.6.3 In Vitro Fertilization
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Fertility Clinics
9.10.2 Hospitals
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 General
10.6.2 Fertility Medication
10.6.3 In Vitro Fertilization
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Fertility Clinics
10.10.2 Hospitals
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 General
11.6.2 Fertility Medication
11.6.3 In Vitro Fertilization
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Fertility Clinics
11.10.2 Hospitals
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 General
12.6.2 Fertility Medication
12.6.3 In Vitro Fertilization
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Fertility Clinics
12.10.2 Hospitals
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 General
13.6.2 Fertility Medication
13.6.3 In Vitro Fertilization
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Fertility Clinics
13.10.2 Hospitals
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Assisted Reproductive Technology Market: Competitive Dashboard
14.2 Global Assisted Reproductive Technology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Vitrolife
14.3.2 Ferring Pharmaceuticals
14.3.3 Irvine Scientific
14.3.4 Cook Medical
14.3.5 CellCura
14.3.6 EMD Serono
14.3.7 Esco Micro
14.3.8 IKS International (Gonagen Medikal)
14.3.9 INVO Bioscience
14.3.10 IVFtech
14.3.11 Smiths Medical
